

Miles Briggs MSP for Lothian, was born in 1983 and elected to the Scottish Parliament as a Member for Lothian Region in May 2016. Miles is the Scottish Conservative and Unionist Party Spokesperson for Education and Skills. He has previously been the Local Government, Housing & Social Justice Spokesperson. He was previously the party Chief Whip and before then the Shadow Minister for Health. Miles is Co-Convenor of the Parliament’s Cross-Party Group on Cancer.
Michelle Mitchell OBE has been Chief Executive of Cancer Research UK since 2018, leading the world's largest charitable funder of cancer research. She guided the charity through the COVID-19 pandemic and launching its ambitious long-term strategy in 2022. Under her leadership, the charity has invested more than £2bn in life-saving cancer research. Michelle is a trustee of the Francis Crick Institute and a member of The King's Fund General Advisory Council and was previously CEO of the MS Society and Director General of Age UK.
First elected to the Scottish Parliament in 2007, Constance has represented Almond Valley since 2011. She previously worked as a social worker and mental health officer and served as a local councillor. She has held several senior ministerial roles across education, communities, drugs policy and justice. Most recently, she served as Cabinet Secretary for Justice and Home Affairs for over three years before being appointed Cabinet Secretary for Health and Care in May 2026.

Ally Boyle MBE has been living with blood cancer since 2008 and uses that experience to make positive change. While still serving in fire and rescue, he founded the Scottish Fire and Rescue Service partnership with Anthony Nolan, recruiting thousands to the stem cell register. Years later, Cancer Research UK involvement helped him rebuild confidence, find new purpose, and help form and co-chair Cancer Research UK’s Patient Involvement for early detection and prevention research.
Professor Nigel Jamieson is Chair of Hepatobiliary and Pancreatic Surgery at the University of Glasgow and a Consultant Surgeon at Glasgow Royal Infirmary, specialising in the surgical treatment of patients with pancreatic and liver cancer. He leads an internationally collaborative research group that use the latest generation of molecular imaging technologies and artificial intelligence to understand cancer biology and accelerate the development of new treatments for patients with cancer.
Jamie Cargill is National Nurse Consultant for Children and Young People’s Cancer in Scotland. He provides national leadership across policy, service improvement and cancer care transformation, working with clinicians, researchers, charities, government and healthcare leaders to improve outcomes for children, teenagers and young adults affected by cancer. His interests include reducing inequalities, improving quality, developing the workforce and advancing person-centred care across cancer services.

Jackie Baillie was elected to represent Dumbarton constituency in 1999 and is the only Scottish Labour MSP to have won her seat continuously in every election. Jackie served as the Deputy Minister for Communities, Minister for Social Justice, as well as Economy Spokesperson and Finance Spokesperson. Jackie was elected as Deputy Leader of Scottish Labour in April 2020 and is active within both the GMB and USDAW and is a member of the Cooperative Party.
Thank you to our Scottish Cancer Conference Lived Experience Working Group.
At the heart of this year’s conference is the invaluable contribution of our Lived Experience Working Group, made up of Cancer Research UK Ambassadors and members of the Cancer Research UK Patient Involvement Network. We’re deeply grateful to everyone who generously shared their personal experiences, insights and expertise throughout the planning process. Their openness, honesty and commitment have helped create a conference that puts the voices of people affected by cancer at its centre.
Angela is a wife and mum. She trained as a nurse and worked as an accountant until a dual diagnosis of lung and thyroid cancer in 2024 led to her retirement. Drawing on her professional and lived experience, she has built a third career in patient advocacy and as a trustee of Oncogene Cancer Research. Angela is committed to reducing stigma, raising awareness and supporting research to improve treatment options, with the ambition of making lung cancer a manageable long-term condition.
Freya is a fourth-year International Relations student at the University of Edinburgh and a Campaigns Ambassador for Cancer Research UK. She joined because cancer has profoundly affected her family, including both her father’s survival from childhood leukaemia and her mother’s recent cancer diagnosis and treatment. She is passionate about advocating for sustained political and institutional support for Cancer Research UK.
Iain spent 35 years in policing finishing as a Deputy Chief Constable. In 2018, Iain was diagnosed with Stage 4 Colorectal Cancer with metastasis to the liver and bladder. The cancer spread was inoperable, and he initially commenced palliative chemotherapy. He then was offered targeted therapy and the combination got him to surgery, with no recurrence since. He has been a Cancer Research UK Policy and Communications Cancer Insights Panel member and now is a Campaigns Ambassador.
Jenni found out she carried a BRCA2 gene mutation, meaning she was at a much higher risk of developing cancer. In 2021, she was diagnosed with bilateral breast cancer. Five years later, after treatment and a double mastectomy, Jenni is able to use her experience to support, inform and shape the way for others. Jenni works for two charities: Candu (Dundee Cancer Support Network) and Home-Start Angus and gets real satisfaction working in the third sector.
After being diagnosed with breast cancer at 25, Jenni joined Cancer Research UK’s Policy and Communications Patient Insight Panel for two years, contributing her lived experience to cancer policy and communications. She’s now five years cancer free and remains on maintenance treatment. Having attended last year’s Scottish Cancer Conference, she’s delighted to contribute to this year’s conference through the Lived Experience Working Group.
Jenni was diagnosed with stage 4 ovarian cancer in 2022 and had six cycles of chemotherapy followed by complex 12-hour surgery including a hysterectomy, distal pancreatectomy, splenectomy, gallbladder removal and permanent stoma. Complications following surgery meant she lived with an abdominal wall drain for two and half years. Since this, Jenni completed a Race for Life and has embraced HIIT and strength training, including an 80kg deadlift and 65kg back squat.
Jo’s wife, Sue, was diagnosed with a rare hereditary cancer in 1993 and received pioneering treatment at the Beatson, extending her life by 10 years. After her death in 2003, genetic testing revealed that two of their children and a grandchild had inherited the faulty gene. To improve outcomes, Jo founded The Phaeo and Para Cancer Charity to advance research and develop treatments. A Cancer Research UK Campaigns Ambassador since 2013, he was awarded an MBE for services to charity and cancer research advocacy.
Lesley has lived with secondary, de novo, breast cancer since 2005. She received chemotherapy, targeted therapy and a mastectomy, and remains on Herceptin treatment. She is medically retired after working as a MRI radiographer. In 2025, Lesley became a Cancer Research UK Campaigns Ambassador to share her experience and offer hope to others living with cancer. She advocates for the role of research and clinical trials to help improve outcomes for people with cancer.
Shaumya is a medical student currently undertaking her MB-PhD in Cancer Sciences at the University of Glasgow. She was diagnosed with lymphoma as a teenager in 2020. Shaumya has been part of several Cancer Research UK patient involvement projects, including the Children and Young People’s Insights Panel. In 2024, she became a Cancer Research UK Campaigns Ambassador, and has enjoyed speaking to MPs and MSPs to make cancer a priority on the political agenda.
David grew up in Edinburgh, trained in the West of Scotland and became a GP on the Isle of Arran for 9 years.
In 2019 he moved to East Lothian, where he continued as a portfolio GP. He is an honorary lecturer at Glasgow and Edinburgh universities, and honorary lifeboat medical adviser with the RNLI. In 2023 he was found to have a brain tumour. He has had to stop working but continues some voluntary roles. He is grateful for the care he has received. He has a 6 year old daughter who wants to become a neurosurgeon when she is older.
Dr Rosalind Adam is an academic GP and Senior Clinical Lecturer at the University of Aberdeen. She is Research Lead for the Institute of Applied Health Sciences, co-director of the Scottish School of Primary Care and serves on the Executive Committee of the Cancer in Primary Care International Network. Rosalind has special interests in pain and symptom management and the role of digital health in cancer care. She is currently investigating whether cancer could and should be integrated into chronic disease management in primary care.
David has extensive experience of over 20 years in the NHS, private and nonprofit sectors. At Edinburgh Maggie’s centre he has leadership and governance responsibilities for activity within the centre.
He provides assessment and intervention for people living with the impact of cancer, using a range of psychotherapeutic formats and support.
His approach is influenced by cognitive behavioural therapy and compassion focused therapy. David helps adults to find ways of living with long term chronic health conditions and anxiety disorders.
Emma works on the Scottish Government-funded Cancer Medicines Outcomes Programme-Public Health Scotland (CMOP-PHS). Emma also co-chairs the Scottish Cancer Patient Reported Outcome Measures (PROMs) Advisory Group, and has been working in PROMs for 10 years. She also leads CMOP-PHS’s patient & public involvement and engagement (PPIE) work. Emma’s background is in Psychology and mental health. Her previous research interests have included digital health, palliative care and robotics in medicines’ distribution.
Patient Advocate working with Myeloma UK, Myeloma Patients Europe and Amyloidosis UK. Board member of Blood Cancer Alliance and CMOP-PHS Programme.
Julie is the lead pharmacist for the Cancer Medicines Outcomes Programme-Public Health Scotland (CMOP-PHS). She has been working with the programme since 2016 to maximise the use of routinely collected data to support patients and clinicians to make decisions that are right for them. Away from data she sees patients receiving treatment for melanoma.
Gabrielle works on medicines access policy at Myeloma UK. This includes working on health technology appraisals related to all new myeloma treatments which are being assessed by the National Institute of Health and Care Excellence (NICE) and the Scottish Medicines Consortium (SMC). She holds a PhD in Population Health and following a postdoc, has worked in health policy in terminal illness, bloodborne viruses, and blood cancer.
Vicky leads the UK oncology medical team at AstraZeneca. Since joining the company in 2020, she has played a key role in designing and delivering foundational programmes to optimise cancer care pathways across the UK.
Vicky holds a first-class honours degree in Biomedical Sciences from the University of Bradford and a PhD in Molecular Biology from St George’s Hospital Medical School, University of London. She transitioned to industry and since then has held various commercial, medical and leadership roles across several pharmaceutical companies.
Ezra is the Communications and Public Affairs Manager at OUTpatients, the UK’s LGBTIQ+ cancer charity. OUTpatients is a patient-led organisation working to improve experiences and outcomes for LGBTIQ+ people living with and beyond cancer. They achieve this by providing peer support, shaping national policy, and delivering targeted awareness campaigns for the community, most recently in the form of a Lung Cancer Screening campaign delivered in partnership with Greater Manchester Cancer Alliance and sponsored by AstraZeneca.
Ahsan Akram is Professor of Thoracic Oncology and Imaging and a UKRI Future Leaders Fellow at the University of Edinburgh, and Honorary Consultant in Respiratory Medicine at NHS Lothian. He is National Co-Clinical Lead (Respiratory) for Lung Cancer Screening in Scotland. His research explores the lung cancer microenvironment and translational optical and PET imaging for earlier diagnosis. He has contributed to national pulmonary nodule guidelines and is on funding panels for CRUK and MRC.
Dr Gillian Shirreffs is an author whose “darkly funny, sharply observed” debut novel Brodie raised over £30,000 for Beatson Cancer Charity. Her book, Elephant, centres on a writer facing a breast cancer diagnosis. Told through messages, emails, photos, and interior thoughts, it captures the chaos, loneliness, absurdity and clarity that come when life tilts suddenly and irrevocably. In a previous life, Gillian was an HR Director, living and working on both sides of the Atlantic. In another previous life, she was an English teacher. She has a Doctor of Fine Arts degree in Creative Writing from the University of Glasgow.
At the age of 50 in Dec 2019, Kevin was diagnosed with life limiting and incurable Stage 4 Metastatic Melanoma, with a tumour on his lung and one next to his spine.
Kevin’s experience of his diagnosis and Immunotherapy treatment during Covid in 2020 was isolating as he didn’t know anyone with Melanoma nor people diagnosed with stage 4 cancer, which impacted his mental health. Through a Melanoma Zoom group he found his tribe, and the power of sharing his story and listening to others gave him Hope and led to the book Stories of Cancer and Hope.
Dr Lori Delaney is a Scottish practice-based researcher whose interdisciplinary work explores performance as a space for knowledge production, critical inquiry, social engagement, and wellbeing. She works across research, producing, dramaturgy, and directing, creating collaborative performance practices that foreground lived experience and challenge dominant cultural narratives. Holding a Doctorate from the University of Glasgow, she has over a decade of experience across theatre, education, and community settings. Her research uses devising, autobiographical performance, and participatory methods to foster dialogue, reflection, social change, wellbeing, evaluation, and inclusive creative engagement. Through integrating artistic practice and research, she develops accessible, innovative projects collaboratively.
Ella Mercer is PRIME Manager at brainstrust, leading the charity's patient and public involvement and engagement (PPIE) programme in brain tumour research. With a background as a preclinical scientist, she brings together scientific expertise and experience in patient involvement to build meaningful partnerships between researchers, patients and caregivers. Her work focuses on ensuring that people affected by brain tumours are active partners in shaping research priorities, study design and outcomes that matter to patients.
Amy is a 31-year-old accountant, from West Lothian. In August 2023 she was diagnosed with a Grade 4 Astrocytoma brain tumour. After 2 surgeries to remove as much of the tumour as possible, under 10% was and is still here. From daily sessions of chemotherapy & radiotherapy for six weeks and then additional chemo for six months, she has now recovered well and is continuing to fight every day.
As Public Engagement and Involvement Manager for the Institute of Genetics and Cancer, University of Edinburgh, Jen supports researchers in sharing their work with the wider public, through public talks, workshops, and festivals. She also supports researchers in connecting with people directly affected by cancers and rare diseases, to ensure the Institute’s work is shaped by their needs and priorities. She is passionate about embedding patient voices in research, creating opportunities for shared learning, and increasing learning opportunities for underserved groups.
Find out more and join Scotland’s flagship cancer event, bringing together voices from research, care and advocacy.
Read about the individual breakout sessions that will focus on the core stages of the cancer pathway.
Meet the organisations exhibiting at the conference and find out about the support, resources and opportunities they offer.
View the full programme and session timings.(PDF, 6.48 MB)
If you would like to receive future conference updates, including programme announcements and speaker information, please contact us to be added to the mailing list.